Package 63824-041-24

{"route": ["ORAL"], "spl_id": "302b8792-38f6-a209-e063-6294a90af24f", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1244675"], "spl_set_id": ["d9264518-2f2c-498f-b733-6f3397336a01"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["RB Health (US) LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (63824-041-24)  / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "63824-041-24", "marketing_start_date": "20120626"}], "brand_name": "Mucinex D Maximum Strength", "product_id": "63824-041_302b8792-38f6-a209-e063-6294a90af24f", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "63824-041", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "RB Health (US) LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucinex D", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "NDA021585", "marketing_category": "NDA", "marketing_start_date": "20120626", "listing_expiration_date": "20261231"}